ALNY Competitors & Alternatives
Compare Alnylam Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
ALNY
Main Stock$219.72
Tradestie Score
49
Market Cap
$60.38B
P/E Ratio
42.9
Revenue Growth
0.7%
Analyst Upside
+68.9%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ARGX
argenx SE American Depositary Shares
|
$919.21
|
$46.96B | 35.7 | 52 | Compare |
|
ONC
BeOne Medicines Ltd. American Depositary Shares
|
$358.07
|
$36.81B | 64.1 | 56 | Compare |
|
INSM
Insmed, Inc.
|
$111.12
|
$31.13B | - | 49 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$96.90
|
$24.57B | - | 55 | Compare |
|
GMAB
Genmab A/S ADS
|
$34.75
|
$19.56B | 27.2 | 47 | Compare |
|
INCY
Incyte Genomics Inc
|
$115.30
|
$16.93B | 15.5 | 56 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$57.16
|
$15.70B | 31.3 | 70 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$16.76
|
$15.22B | - | 49 | Compare |
|
NBIX
Neurocrine Biosciences Inc
|
$143.18
|
$13.59B | 20.8 | 62 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$227.87
|
$12.36B | 17.9 | 66 | Compare |
More ALNY Analysis
Data updated: Oct 04, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry